Comments
Loading...

Cadrenal Therapeutics

CVKDNASDAQ
Logo brought to you by Benzinga Data
$14.77
0.513.58%
At close: -
$13.93
-0.84-5.70%
After Hours: 4:38 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$32.00
Lowest Price Target1
$4.00
Consensus Price Target1
$18.00

Cadrenal Therapeutics (NASDAQ:CVKD) Stock, Analyst Ratings, Price Targets, Forecasts

Cadrenal Therapeutics Inc has a consensus price target of $18 based on the ratings of 2 analysts. The high is $32 issued by HC Wainwright & Co. on November 11, 2024. The low is $4 issued by Noble Capital Markets on December 18, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on November 11, 2024, June 6, 2024, and May 9, 2024, respectively. With an average price target of $12.67 between HC Wainwright & Co., there's an implied -9.06% downside for Cadrenal Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Noble Capital Markets

1calculated from analyst ratings

Analyst Ratings for Cadrenal Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cadrenal Therapeutics (CVKD) stock?

A

The latest price target for Cadrenal Therapeutics (NASDAQ:CVKD) was reported by HC Wainwright & Co. on November 11, 2024. The analyst firm set a price target for $32.00 expecting CVKD to rise to within 12 months (a possible 129.75% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cadrenal Therapeutics (CVKD)?

A

The latest analyst rating for Cadrenal Therapeutics (NASDAQ:CVKD) was provided by HC Wainwright & Co., and Cadrenal Therapeutics maintained their buy rating.

Q

When was the last upgrade for Cadrenal Therapeutics (CVKD)?

A

There is no last upgrade for Cadrenal Therapeutics

Q

When was the last downgrade for Cadrenal Therapeutics (CVKD)?

A

There is no last downgrade for Cadrenal Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cadrenal Therapeutics (CVKD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cadrenal Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cadrenal Therapeutics was filed on November 11, 2024 so you should expect the next rating to be made available sometime around November 11, 2025.

Q

Is the Analyst Rating Cadrenal Therapeutics (CVKD) correct?

A

While ratings are subjective and will change, the latest Cadrenal Therapeutics (CVKD) rating was a maintained with a price target of $3.00 to $32.00. The current price Cadrenal Therapeutics (CVKD) is trading at is $13.93, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch